Skip to main content

Glossary N

Glossary · Pharma

Non-GxP

Area
Pharma IT
Related
GxP, Validation, PIC/S, QA

Non-GxP describes a system that its operator does not classify as GxP-relevant; PIC/S guidance uses the term without defining it formally.

The company that operates a system decides how it is classified; we do not classify our customers' systems. The PIC/S guidance document PI 041-1 expects these regulated users, as it calls them, to keep an inventory of all computerised systems in use, with an assessment of the function and criticality of each system and its data. It gives three example levels: direct GMP/GDP impact, indirect impact and no impact. For manufacturing, Annex 11 of the EU GMP Guide says an up-to-date listing of all relevant systems and their GMP functionality should be available.

The term appears, undefined, in PI 011-3. It says retrospective validation might be justified if a non-GxP system is newly classified as a GxP system, so a classification is not fixed. It also says the reasoning behind critical or non-critical classifications should be documented, and that any risk potentially affecting GxP compliance should be clearly identified.

Our business applications for the pharma sector are intended for settings the operator classifies as non-GxP. We do not offer computer system validation for them: we produce no IQ/OQ/PQ documentation (see Validation) and do not follow a GAMP 5 approach (see GAMP). In one tender, a pharma company's own user requirements specification classified the portal it wanted built as non-GxP. That classification did not mean the portal had no requirements.

Where the term appears

Sources

  1. EudraLex Volume 4, Annex 11: Computerised Systems (Revision 1, in Kraft seit 30. Juni 2011) (opens in a new tab)

    Europäische Kommission, Generaldirektion Gesundheit accessed

Let's talk about your project.

If this term is on your desk right now, a conversation usually helps faster than any definition.

Search the website

Popular topics

All results